J
Jonathan Dang
Researcher at Cedars-Sinai Medical Center
Publications - 12
Citations - 463
Jonathan Dang is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Major depressive disorder & Quality of life. The author has an hindex of 6, co-authored 11 publications receiving 270 citations.
Papers
More filters
Journal ArticleDOI
Pain and Depression: A Systematic Review.
Waguih William IsHak,Raymond Y Wen,Lancer Naghdechi,Brigitte Vanle,Jonathan Dang,Michelle Knosp,Julieta Dascal,Lobsang Marcia,Yasmine Gohar,Lidia Eskander,Justin Yadegar,Sophia Hanna,Antonious Sadek,Leslie Aguilar-Hernandez,Itai Danovitch,Charles Louy +15 more
TL;DR: In this article, a systematic search of the literature databases was conducted according to predefined criteria, and two authors independently conducted a focused analysis of the full-text articles and reached a consensus on 28 articles to be included in this review.
Journal Article
The Assessment and Measurement of Wellness in the Clinical Medical Setting: A Systematic Review
Ryan Bart,Waguih William IsHak,Shaina Ganjian,Karim Yahia Jaffer,Marina Abdelmesseh,Sophia Hanna,Yasmine Gohar,Gezelle Azar,Brigitte Vanle,Jonathan Dang,Itai Danovitch +10 more
TL;DR: There is insufficient evidence to support the clinical utility of a single particular wellness instrument, and properly defining wellness might help drive the development and validation of more precise assessment and measurement methods.
Journal Article
Trazodone for Insomnia: A Systematic Review.
Karim Yahia Jaffer,Tiffany Chang,Brigitte Vanle,Jonathan Dang,Alexander J Steiner,Natalie Loera,Marina Abdelmesseh,Itai Danovitch,Waguih William IsHak +8 more
TL;DR: A review of the literature suggests that there are adequate data supporting the efficacy and general safety of the low-dose use of trazodone for the treatment of insomnia.
Journal ArticleDOI
The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder
TL;DR: Evidence is provided that continuing SSRIs for 1 year reduces risk of MDD and relapse, and the combination of SSR is and cognitive behavioural therapy may effectively reduce relapse.
Journal ArticleDOI
Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study
Alexander J Steiner,Jennifer Recacho,Brigitte Vanle,Jonathan Dang,Stephanie M. Wright,Justin S Miller,Kaitlyn Kauzor,Mark W. Reid,Luma Bashmi,James Mirocha,Itai Danovitch,Itai Danovitch,Waguih William IsHak +12 more
TL;DR: Findings suggest that older adults and younger adults have comparable treatment responses to citalopram monotherapy, with significant improvements in patient-reported depressive symptom severity, functioning, and QOL.